Cardlytics Stock Forecast, Price & News

-6.80 (-6.06 %)
(As of 04/13/2021 12:00 AM ET)
Today's Range
Now: $105.50
50-Day Range
MA: $123.79
52-Week Range
Now: $105.50
Volume1.14 million shs
Average Volume482,501 shs
Market Capitalization$3.35 billion
P/E RatioN/A
Dividend YieldN/A
Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
Cardlytics logo

Industry, Sector and Symbol

Industry Computer programming, data processing, & other computer related
Current SymbolNASDAQ:CDLX
Phone(888) 798-5802
Year FoundedN/A



Sales & Book Value

Annual Sales$210.43 million
Book Value$6.28 per share


Net Income$-17,140,000.00


Market Cap$3.35 billion
Next Earnings Date5/10/2021 (Estimated)
OptionableNot Optionable


5 Red-Hot Big Bank Earnings Charts - Nasdaq
April 13, 2021 |
Cardlytics (CDLX) to Acquire Bridg -
April 13, 2021 |
Cardlytics (NASDAQ:CDLX) Trading Down 6.2%
April 13, 2021 |
Cardlytics (NASDAQ:CDLX) Shares Up 7.7%
April 1, 2021 |
Cardlytics closes $275M deal for Dosh - Seeking Alpha
March 10, 2021 |
Cardlytics Completes Acquisition of Dosh
March 9, 2021 |
See More Headlines


Overall MarketRank

1.10 out of 5 stars

Business Services Sector

200th out of 442 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

46th out of 74 stocks

Analyst Opinion: 1.1Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
-6.80 (-6.06 %)
(As of 04/13/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CDLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Cardlytics (NASDAQ:CDLX) Frequently Asked Questions

Is Cardlytics a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Cardlytics stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDLX, but not buy additional shares or sell existing shares.
View analyst ratings for Cardlytics
or view top-rated stocks.

What stocks does MarketBeat like better than Cardlytics?

Wall Street analysts have given Cardlytics a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cardlytics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Cardlytics' next earnings date?

Cardlytics is scheduled to release its next quarterly earnings announcement on Monday, May 10th 2021.
View our earnings forecast for Cardlytics

How were Cardlytics' earnings last quarter?

Cardlytics, Inc. (NASDAQ:CDLX) released its quarterly earnings results on Sunday, February, 28th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.02. The business had revenue of $67.08 million for the quarter, compared to analysts' expectations of $60.84 million. Cardlytics had a negative trailing twelve-month return on equity of 31.98% and a negative net margin of 23.91%. The firm's revenue was down 3.2% on a year-over-year basis. During the same quarter last year, the company posted $0.18 EPS.
View Cardlytics' earnings history

How has Cardlytics' stock price been impacted by COVID-19?

Cardlytics' stock was trading at $45.83 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CDLX shares have increased by 130.2% and is now trading at $105.50.
View which stocks have been most impacted by COVID-19

What guidance has Cardlytics issued on next quarter's earnings?

Cardlytics updated its FY 2021 Pre-Market earnings guidance on Monday, March, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $250-275 million, compared to the consensus revenue estimate of $255.59 million.

What price target have analysts set for CDLX?

6 Wall Street analysts have issued 12-month target prices for Cardlytics' shares. Their forecasts range from $75.00 to $150.00. On average, they anticipate Cardlytics' stock price to reach $107.50 in the next year. This suggests a possible upside of 1.9% from the stock's current price.
View analysts' price targets for Cardlytics
or view top-rated stocks among Wall Street analysts.

Who are Cardlytics' key executives?

Cardlytics' management team includes the following people:
  • Lynne Marie Laube, Chief Executive Officer & Director
  • Peter Davies, Head-Sales Strategy & Operations
  • Andrew Christiansen, Chief Financial & Accounting Officer
  • Sathish Gaddipati, Chief Technology Officer
  • Manohar Reddy Dendi, Engineering Director

What is Scott Grimes' approval rating as Cardlytics' CEO?

63 employees have rated Cardlytics CEO Scott Grimes on Scott Grimes has an approval rating of 86% among Cardlytics' employees.

Who are some of Cardlytics' key competitors?

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA), Square (SQ), DocuSign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), The Walt Disney (DIS), Alibaba Group (BABA), The Trade Desk (TTD), QUALCOMM (QCOM) and Twilio (TWLO).

When did Cardlytics IPO?

(CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

What is Cardlytics' stock symbol?

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

Who are Cardlytics' major shareholders?

Cardlytics' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (0.13%) and Acorn Financial Advisory Services Inc. ADV (0.04%). Company insiders that own Cardlytics stock include Aimia Inc, Andrew Christiansen, Bryce Youngren, Clifford Sosin, David Leslie Adams, David Thomas Evans, John L Jr Klinck, John V Balen, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Polaris Venture Management Co, Scott D Grimes and Tony Weisman.
View institutional ownership trends for Cardlytics

Which major investors are selling Cardlytics stock?

CDLX stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, and Acorn Financial Advisory Services Inc. ADV. Company insiders that have sold Cardlytics company stock in the last year include Andrew Christiansen, Bryce Youngren, David Leslie Adams, David Thomas Evans, John L Jr Klinck, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Scott D Grimes, and Tony Weisman.
View insider buying and selling activity for Cardlytics
or view top insider-selling stocks.

How do I buy shares of Cardlytics?

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardlytics' stock price today?

One share of CDLX stock can currently be purchased for approximately $105.50.

How much money does Cardlytics make?

Cardlytics has a market capitalization of $3.35 billion and generates $210.43 million in revenue each year. The company earns $-17,140,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis.

How many employees does Cardlytics have?

Cardlytics employs 486 workers across the globe.

What is Cardlytics' official website?

The official website for Cardlytics is

Where are Cardlytics' headquarters?

Cardlytics is headquartered at 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308.

How can I contact Cardlytics?

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at (888) 798-5802 or via email at [email protected]

This page was last updated on 4/14/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.